Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers--insights from the bench side
about
Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkersMAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary FibrosisNrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosisMMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosisDeficiency of α7 nicotinic acetylcholine receptor attenuates bleomycin-induced lung fibrosis in mice[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosisReduced FoxO3a expression causes low autophagy in idiopathic pulmonary fibrosis fibroblasts on collagen matrices.Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis.iTRAQ-Based Proteomics Reveals Novel Biomarkers for Idiopathic Pulmonary Fibrosis.The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosisA protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repairPathogenesis of idiopathic pulmonary fibrosis and its clinical implications.Safety of mTOR inhibitors in adult solid organ transplantation.Earthworm extract attenuates silica-induced pulmonary fibrosis through Nrf2-dependent mechanisms.Radiation induced pulmonary fibrosis as a model of progressive fibrosis: Contributions of DNA damage, inflammatory response and cellular senescence genes.Nintedanib (OFEV) in the treatment of idiopathic pulmonary fibrosis.Targeting coagulation factor receptors - protease-activated receptors in idiopathic pulmonary fibrosis.Meprin β contributes to collagen deposition in lung fibrosis.Plasma Vascular Endothelial Growth Factor Concentration and Alveolar Nitric Oxide as Potential Predictors of Disease Progression and Mortality in Idiopathic Pulmonary Fibrosis.Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis.ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s.Desensitization of idiopathic pulmonary fibrosis fibroblasts to Alternaria alternata extract-mediated necrotic cell death.Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis.Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activationFibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis.Cellular senescence-like features of lung fibroblasts derived from idiopathic pulmonary fibrosis patients.ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling.Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair.Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions.Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial-mesenchymal transition.Rapamycin protects against paraquat-induced pulmonary epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury.Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosis
P2860
Q26864836-69C5E926-60AA-4A15-B6A4-CFC052AB1B72Q27348347-BF383ABD-46A0-47AA-84E0-B42C9B13D64DQ28396556-6B8958D9-BFE1-4C89-AA66-3A3668EECE46Q33574837-B5141A70-B0FD-4C8A-8FD6-A468A5EE313CQ33609688-BA15BD46-C201-4592-B09A-CAF13FF77F37Q33612767-76305454-E731-4424-A1C2-715D1EFCB181Q35558781-113A1639-B05E-49D9-A354-FBBA3912871EQ36066475-B130E583-5DA5-4D26-9596-752EAAF040CAQ36248048-0BBC92E3-7D8D-4CDE-B03D-79A33A58926DQ36259789-AA612284-8C50-47E5-B281-E870F2BA87C2Q36326780-FFC025B5-A0E2-4B02-BA9E-CB807C36685CQ36438280-5F696769-5C04-4191-A7D5-8AEAF7F38033Q38222245-6C5E4010-DE05-47EC-8E93-CF34D79254FAQ38669190-2DEA010A-92BA-4DC2-AA22-730C3DA433B7Q38738032-686DBC80-4B21-476D-BADF-BB65E79090EEQ38769339-03DA3060-6E31-4E07-9707-5BF6ED04698CQ38981777-C9CA7FDC-8922-49B8-929F-BECE451F0086Q39024744-19B4933C-C177-4FA7-977C-DE68FA7172C7Q39036654-16022590-B177-4CDF-BBDC-C4D086206515Q39401141-66754864-FEC2-4F31-A058-C6FAE024A797Q39415339-80FF934F-EE35-4155-B3A6-A6DEF042F6C9Q40219134-0717F968-E2F2-4514-A376-0B4E138C05A3Q40428318-D4D41278-A7D2-4AE2-993D-DED328D81AFBQ41557414-6009AC30-ED8E-49C3-902C-F341C168333EQ41617768-68921559-E7C7-4352-A761-C34BF558281CQ42804790-7C9496F5-F57D-49CB-A771-6B40D1DC2BC9Q43227157-585118C9-4B7F-4B1E-8B5A-8BE4931F7677Q46670121-CB2F0348-B8FA-448D-ADD6-0C28E250AC31Q47235420-90D656FA-4857-4DE6-8BD7-CD48FED34F70Q51233185-02A0CFA6-B386-4F8A-AC2A-EF91F79A3B12Q51590827-FB0DEBDC-3158-40CA-8BB7-1D9180E6A837Q54093489-EB90158A-2C13-467E-B079-3CBA0D995762Q55387631-762801C2-79AB-4FC9-A473-43D93E56AD0BQ58747855-4C50A28A-1050-48E4-A95E-C93761DA6B29
P2860
Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers--insights from the bench side
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Idiopathic pulmonary fibrosis: ...... --insights from the bench side
@ast
Idiopathic pulmonary fibrosis: ...... --insights from the bench side
@en
Idiopathic pulmonary fibrosis: ...... --insights from the bench side
@nl
type
label
Idiopathic pulmonary fibrosis: ...... --insights from the bench side
@ast
Idiopathic pulmonary fibrosis: ...... --insights from the bench side
@en
Idiopathic pulmonary fibrosis: ...... --insights from the bench side
@nl
prefLabel
Idiopathic pulmonary fibrosis: ...... --insights from the bench side
@ast
Idiopathic pulmonary fibrosis: ...... --insights from the bench side
@en
Idiopathic pulmonary fibrosis: ...... --insights from the bench side
@nl
P2093
P921
P3181
P356
P1433
P1476
Idiopathic pulmonary fibrosis: ...... --insights from the bench side
@en
P2093
Bruno Crestani
Keren Borensztajn
Martin Kolb
P304
P3181
P356
10.1159/000357598
P407
P577
2013-01-01T00:00:00Z